Context Therapeutics amended charter to authorize 310 million shares
Context Therapeutics amended its charter to authorize 310 million shares. The increase supports potential future financing needs.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Context Therapeutics amended its charter to authorize 310 million shares. The increase supports potential future financing needs.
SuRo Capital Corp. filed an amendment to change its corporate name to Neostellar Capital Corp. in preparation for a July 1, 2026 effective date. This restructuring will occur witho…
SCYNEXIS amends its certificate of incorporation to authorize 65 million shares. The approval, received in June 2026, establishes the corporate equity capacity for potential future…
Quince Therapeutics adopted a 1-for-20 reverse stock split effective June 2026 following board and shareholder approval. This corporate restructuring consolidates outstanding share…
HCW Biologics implemented a 1-for-6 reverse stock split effective June 30, 2026. This corporate action aims to increase the share price to meet listing requirements and enhance mar…
This filing outlines a corporate restructuring plan to relocate the company's domicile from Delaware to Nevada. The transition is contingent upon the timely execution and filing of…
Forgent Power Solutions, Inc. entered into an amendment to its Credit Agreement on June 23, 2026 to refinance term loans. This debt restructuring action typically helps manage liqu…
Live Oak Acquisition Corp. V has amended its certificate of incorporation to change its name to Teamshares Inc and domesticate to Delaware. This change establishes the company's le…
ULIXE ITALY S.R.L. has transferred its equity interest in ULIXE NOVA S.R.L. to CONDOTTI CAPITAL S.R.L. The transferor agreed to a corporate name change to NOVA AI TECHNOLOGY S.R.L.…
BitGo announced a workforce reduction of nearly 15% as the company adjusts its strategy to prioritize core services like security and trading. The move is intended to ensure the fi…
Blue Owl NLT Operating Partnership LP amended its credit agreement effective June 18, 2026. The amendment involves deletions and additions to the facility terms subject to conditio…
First Trust Senior Floating Rate Fund II shareholders approved a plan to reorganize into a new ETF. The conversion is expected to close on August 10, 2026, subject to customary con…
Public Storage Operating Company entered into a Fourth Amended and Restated Credit Agreement with a syndicate of financial institutions, amending its revolving and term loan facili…
SmartStop Self Storage REIT reclassified its Class A and T shares into Common Stock and increased authorized shares to 225 million. This amendment secures the Board's authority for…
Lord Abbett PCF Financing amends the revolving credit facility and transfers custodian roles to State Street and Computershare; this administrative update indicates no material fin…
Cytosorbents Corp presented its business strategy during the Life Sciences Forum, focusing on a restructuring of the German sales team and a strategic workforce reduction plan. The…
Range Capital Acquisition Corp. shareholders approved amendments to extend the deadline to finalize a business combination to up to 27 months, including conditions for sponsor-fund…
Milestone Scientific Inc. cancelled consulting agreements and modified compensation arrangements with Leonard Osser. This restructuring outlines liabilities and terms for the execu…
FedEx announced cash tender offers with a maximum principal amount of $4.15 billion. The transaction is designed to reduce debt and achieve a leverage-neutral profile after the Fed…
Pitney Bowes Inc. (PBI) entered into a Fourth Amendment to its Credit Agreement securing $150 million in incremental Tranche A Term Loans. The proceeds will be used to redeem and r…